Traitement de l'ulcère peptidique

Patent europeic · EP0225044 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP0225044
Numer da la dumonda
EP86308333
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
27-10-1986
Publitgà
10-06-1987
Concedì
28-08-1991
Stritgà
31-10-1993
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 31/557 (2006.01)
Prioritad
US A 791673 28.10.1985
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 24-10-2024

    Stritgà, taxa betg pajada

    Published in Swissreg on 24.10.2024

  2. 15-10-1991

    Concedì

    Published in PIDTJ No 19 in 1991

Partidas

Possessur

Ortho Pharmaceutical Corporation

U.S. Route 202 P.O. Box 300, Raritan/NJ, US

Represchentant

E. Blum & Co. Patentanwälte

Am Vorderberg 11, 8044 Zürich

Inventur

Rosenthale, Marvin E.

Princeton, NJ 08540, US

Katz, Laurence B.

Lawrenceville, NJ 08648, US

Shriver, David A.

Martinsville, NJ 08836, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.